Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2007 Jun;92(6):495-8.
doi: 10.1136/adc.2006.102699. Epub 2007 Feb 6.

Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres

Bob Phillips  1 , Karen Selwood, Sheila M Lane, Roderick Skinner, Faith Gibson, Julia C Chisholm; United Kingdom Children's Cancer Study Group
Affiliations
Multicenter Study

Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres

Bob Phillips et al. Arch Dis Child. 2007 Jun.

Abstract

Objective: To assess the variation in the current UK management strategies for the treatment of febrile neutropenia in childhood.

Design and setting: A postal survey of all 21 United Kingdom Children's Cancer Study Group (UKCCSG) centres assessing and collating local policies, protocols or guidelines relating to the management of febrile neutropenia. Further direct contact was undertaken to clarify any uncertainties.

Results: All 21 centres provided information. The policies used to manage febrile neutropenia in the centres around the UK vary in almost every aspect of management. Definitions of fever ranged from a persistent temperature of >37.5 degrees C to a single reading of >39 degrees C. Neutropenia was inconsistently defined as an absolute neutrophil count of <1x10(9), <0.75x10(9 )or <0.5x10(9). Choices of antibiotic approaches, empirical modifications and antistaphylococcal treatment were different in each protocol. The use of risk stratification was undertaken in 11 centres, with six using a policy of reduced intensity therapy in low risk cases. Empirical antifungal treatment was very poorly described and varied even more widely.

Conclusions: There was a great deal of variation in definitions and treatment of febrile neutropenia in the UKCCSG children's cancer treatment centres. A degree of variation as a result of local microbiological differences is to be expected, but beyond this we should seek to standardise the core of our approach to defining fever and neutropenia, risk stratification and duration of empirical therapy in a way that maintains safety, minimises resource utilisation and maximises quality of life.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

References

    1. Orudjev E, Lange B J. Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol 200239(2)77–85. - PubMed
    1. Hann I, Viscoli C, Paesmans M.et al A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 199799(3)580–588. - PubMed
    1. Klastersky J, Paesmans M, Rubenstein E B.et al The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low‐risk febrile neutropenic cancer patients. J Clin Oncol 200018(16)3038–3051. - PubMed
    1. Viscoli C, EORTC International Antimicrobial Therapy Group Management of infection in cancer patients. Studies of the EORTC International Antimicrobial Therapy Group (IATG). Eur J Cancer 200238(Suppl 4)S82–S87. - PubMed
    1. National Institute of Clinical Excellence ( N I C E )Guidance on cancer services: improving outcomes in child and adolescent cancer. London: The Stationery Office, 2003

Publication types

MeSH terms